New recombinant serotypes of AAV vectors

Current Gene Therapy

Volumn 5, Issue 3, 2005, Pages 285-297

  Gao, Guangping ^a   Vandenberghe, Luk H ^b   Wilson, James M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; BETA ACTIN; BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DYSTROPHIN; ERYTHROPOIETIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PARVOVIRUS VECTOR; SARCOGLYCAN; VASCULOTROPIN;

CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMOPHILIA A; HEMOPHILIA B; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MOLECULAR PHYLOGENY; NONHUMAN; PHENOTYPE; PROVIRUS; REPORTER GENE; REVIEW; SEROPREVALENCE; SEROTYPE; SOMATIC GENE THERAPY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIROGENESIS; VIRUS CAPSID; VIRUS GENOME; VIRUS ISOLATION; VIRUS RECOMBINANT;

ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; HUMANS; PHYLOGENY; RECOMBINATION, GENETIC;

MIRIDAE; PRIMATES;

EID: 21244460769     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523054065057     Document Type: Review

References (60)

1. Antonarakis, S. and Kazazian, H. (1998). "The molecular basis of hemophilia A in man." Trends Genet. 4: 233-237.
2. Arbetman, A., Lochrie, M. Randlev, B., Surosky, R., Zhou, S., Wellman, J., Pater, C., Lehmkuhl, H., Hobbs, L., Pierce, G. and Colosi, P. (2004a). Isolation of a Close AAV5 Relative from Goal Tissues: Evidence of Host Promiscuity. ASGT 7th Annual Meeting, Minneapolis, MN.
3. Arbetman, A., Lochrie, M. Randlev, B., Surosky, R., Zhou, S., Wellman, J., Pater, C., Lehmkuhl, H., Hobbs, L., Pierce, G. and Colosi, P. (2004b). Characterization of Novel Caprine and Bovine AAV Capsids with Unique Transduction and Neutralization Properties. Xth Parvovirus Workshop, St. Petersburg, FL.
4. Atchison, R. W., Casto, B. C. and Hammon, W. M. (1965). "Adenovirus-Associated Defective Virus Particles." Science 149: 754-6.
5. Auricchio, A., Kobinger, G., Anand, V., Hildinger, M., O'Connor, E., Maguire, A. M. Wilson, J. M. and Bennett, J. (2001). "Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model." Hum. Mol. Genet. 10(26): 3075-81.
6. Bantel-Schaal, U., Delius, H., Schmidt, R. and zur Hansen, H. (1999). "Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses." J. Virol. 73(2): 939-47.
7. Bantel-Schaal, U. and Hausen, H. Z. (1984). "Characterization of the DNA of a Defective Human Parvovirus Isolated from a Genital Site." Virology 134: 52-63.
8. Blacklow, N. R., Hoggan, M. D., Kapikian, A. Z., Austin, J. B. and Rowe, W. P. (1968). "Epidemiology of Adenovirus-Associated Virus Infection in a Nursery Population." Amer. J. Epidemiol. 88: 368-378.
9. Blacklow, N. R., Hoggan, M. D. and Rowe, W. P. (1967). "Isolation of Adenovirus-Associated Viruses from Man." Proc. Natl. Acad. Sci. USA 58: 1410-1415.
10. Blacklow, N. R., Hoggan, M. D. and Rowe, W. P. (1968). "Serologic Evidence for Human Infection with Adenovirus-Associated Viruses." J. Natl. Cancer Inst. 40(2): 319-327.
11. Bossis, I. and Chiorini, J. A. (2003). "Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles." J. Virol. 77(12): 6799-810.
12. Chao, H., Monahan, P. E., Liu, Y., Samulski, R. J. and Walsh, C. E. (2001). "Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors." Mol. Ther. 4(3): 217-22.
13. Chen, C., Jensen, R., Schnepp, B., Clark, K. R. and Johnson, P. (2004). "Characterization of adeno-associated virus sequences in human tissues." Mol. Ther. 9(Suppl. 1): 132.
14. Chenuaud, P., Larcher, T., Rabinowitz, J. E., Provost, N., Cherel, Y., Casadevall, N., Samulski, R. J. and Moullier, P. (2004). "Autoimmune anemia in macaques following erythropoietin gene therapy." Blood 103(9): 3303-4.
15. Chiorini, J. A., Kim, F., Yang, L. and Kotin, R. M. (1999). "Cloning and characterization of adeno-associated virus type 5." J. Virol. 73(2): 1309-19.
16. Chiorini, J. A., Yang, L., Liu, Y., Safer, B. and Kotin, R. M. (1997). "Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles." J. Virol. 71(9): 6823-33.
17. Chirmule, N., Propert, K., Magosin, S., Qian, Y., Qian, R. and Wilson, J. (1999). "Immune responses to adenovirus and adeno-associated virus in humans." Gene Ther. 6(9): 1574-83.
18. Clark, K. R., Chen, C., Jensen, R., Schnepp, B. and Johnson, P. (2004). Characterization of Wild-Type Adeno-Associated Viruses Isolated from Human Tissues. Xth Parvovirus Workshop, St. Petersburg, FL.
19. Davidoff, A. M., Ng, C. Y., Sleep, S., Gray, J., Azam, S., Zhao, Y., McIntosh, J. H., Karimipoor, M. and Nathwani, A. C. (2004). "Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock." J. Virol. Methods 121(2): 209-15.
20. Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A. and Chiorini, J. A. (2000). "Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system." Proc. Natl. Acad. Sci. USA 97(7): 3428-32.
21. Gao, G., Alvira, M. R., Somanathan, S., Lu, Y., Vandenberghe, L. H., Rux, J. J., Calcedo, R., Sanmiguel, J., Abbas, J. and Wilson, J. M. (2003). "Adeno-associated viruses undergo substantial evolution in primates during natural infections." Proc. Natl. Acad. Sci. USA 100(10): 6081-6.
22. Gao, G., Lebherz, C., Weiner, D. J., Grant, R., Calcedo, R., McCullough, B., Bagg, A., Zhang, Y. and Wilson, J. M. (2004). "Erythropoietin gene therapy leads to autoimmune anemia in macaques." Blood 103(9): 3300-2.
23. Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X. and Wilson, J.M. (2004). "Clades of Adeno-associated viruses are widely disseminated in human tissues." J. Virol. 78(12): 6381-8.
24. Gao, G. P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J. and Wilson, J. M. (2002). "Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy." Proc. Natl. Acad. Sci. USA 99(18): 11854-9.
25. Georg-Fries, B., Biederlack, S., Wolf, J. and zur Hausen, H. (1984). "Analysis of proteins, helper dependence, and seroepidentiology of a new human parvovirus." Virology 134(1): 64-71.
26. Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W. and Chamberlain, J. S. (2004). "Systemic delivery of genes to striated muscles using adeno-associated viral vectors." Nat. Med. 10(8): 828-34.
27. Grimm, D. and Kay, M. A. (2003). "From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy." Curr. Gene Ther. 3(4): 281-304.
28. Grimm, D., Zhou, S., Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Matsushita, T., Allen, J., Surosky, R., Lochrie, M., Meuse, L., McClelland, A., Colosi, P. and Kay, M. A. (2003). "Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy." Blood 102(7): 2412-9.
29. Hammill, D., Calcedo, R., Qin, Q., Sanmiguel, J., Gallery, L., Gao, G. and Wilson, J. (2003). Quality Control and Quality Assurance of Novel AAV Vectors for Gene Transfer Studies in Non-human Primates. ASGT 6th Annual Meeting, Washington, DC.
30. Harper, S. Q., Hauser, M. A., Hauser, A., DelloRusso, C., Duan, D., Crawford, R. W., Phelps, S. F., Harper, H. A., Robinson, A. S. (2002). "Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy." Nat. Med. 8(3): 253-61.
31. High, K. A. (2001). "AAV-mediated gene transfer for hemophilia." Ann. N.Y. Acad. Sci. 953: 64-74.
32. Hoggan, M. D., Blacklow, N. R. and Rowe, W. P. (1966). "Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics." Proc. Natl. Acad. Sci. USA 55(6): 1467-74.
33. Jensen, R., Schnepp, B., Johnson, P. and Clark, P. (2004). Adeno-Associated Virus Infection in Non-Human Primates. Xth Parvovirus Workshop, St-Pete's Beach, FL.
34. Kaufman, R. J. (1992). "Biological regulation of factor VIII activity." Annu. Rev. Med. 43: 325-39.
35. Kotin, R. M. (1994). "Prospects for the use of adeno-associated virus as a vector for human gene therapy." Hum. Gene Ther. 5(7): 793-801.
36. Lebherz, C., Gao, G., Louboutin, J. P., Millar, J., Rader, D. and Wilson, J. M. (2004). "Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia." J. Gene Med. 6(6): 663-72.
37. Levy, H., Baker, T., Bowman, V., Warrington, K., Zolotukhin, S., Chen, W., Nash, K., Muzyczka, N. and Agbandje-Mckenna, S. (2004). Structural and Functional Studies of Adeno-Associated Virus (AAV) Capsids. Xth Parvovirus Workshop, St. Petersburg, FL.
38. Lukashov, V. V. and Goudsmit, J. (2001). "Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses." J. Virol. 75(6): 2729-40.
39. Matthews (1982). "Classification and nomenclature of viruses. Fourth report of the International Committee on Taxonomy of Viruses." Intervirology 17(1-3): 1-199.
40. Mayor, H. D. and Ito, M. (1967). "Distribution of Antibodies to Type 4 Adeno-Associated Satellite Virus in Simian and Human Sera." P. S. E. B. M. 26: 723-125.
41. Mayor, H. D. and Melnick, J. L. (1966). "Small Deoxyribonucleic Acid-containing Viruses (Picodnavirus Group)." Nature 210: 331-332.
42. Melnick, J. L., Mayor, H. D., Smith, K. O., Rapp, F. (1965). "Association of 20 millimicron particles with adenoviruses." J. Bacteriol. 90: 271-274.
43. Mori, S., Wang, L., Takeuchi, T. and Kanda, T. (2004). "Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein." Virology 330(2): 375-83.
44. Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X. and Samulski, R. J. (2002). "Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity." J. Virol. 76(2): 791-801.
45. Rabinowitz, J. E. and Samulski, J. (1998). "Adeno-associated virus expression systems for gene transfer." Curr. Opin. Biotechnol., 9(5): 470-5.
46. Rutledge, E. A., Halbert, C. L. and Russell, D. W. (1998). "Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2." J. Virol. 72(1): 309-19.
47. Samulski, R. J., Srivastava, A., Berns, K. I. and Muzyczka, N. (1983). "Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV." Cell 33(1): 135-43.
48. Sarkar, R., Tetreault, R., Gao, G., Wang, L., Bell, P., Chandler, R., Wilson, J. M. and Kazazian, Jr. H. H. (2004). "Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype." Blood 103(4): 1253-60.
49. Schmidt, M., Katano, H., Bossis, I. and Chiorini, J. A. (2004). "Cloning and characterization of a bovine adeno-associated virus." J. Virol. 78(12): 6509-16.
50. Song, S., Scott-Jorgensen, M., Wang, J., Poirier, A., Crawford, J., Campbell-Thompson, M. and Flotte, T. R. (2002). "Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects." Mol. Ther. 6(3): 329-35.
51. Thomas, C. E., Storm, T. A. Huang, Z. and Kay, M. A. (2004). "Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors." J. Virol. 78(6): 3110-22.
52. Wang, A. Y., Peng, P. D., Ehrhardt, A., Storm, T. A. and Kay, M. A. (2004). "Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo." Hum. Gene Ther. 15(4): 405-13.
53. Wang, L., Calcedo, R., Nichols, T., Bellinger, D., Dillow, A., Verma, I. and Wilson, J. (2005). "Sustained Correction of Disease in Naïve and AAV2-pretreated Hemophilia B Dogs: AAV2/8 Mediated, Liver-directed Gene Therapy." Blood in press.
54. Wang, L., Gao, G. and Wilson, J. (2004). 7th NHF Workshop on Novel Technologies and Gene Transfer, Philadelphia, PA.
55. Wang, Z., Zhu, T., Qiao, C., Zhou, L., Wang, B., Zhang, J., Chen, C., Li, J. and Xiao, X. (2005). "Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart." Nat. Biotechnol. 23(3): 321-8.
56. Xiao, W., Chirmule, N. Berta, S. C., McCullough, B., Gao, G. and Wilson, J. M. (1999). "Gene therapy vectors based on adeno-associated virus type 1." J. Virol. 73(5): 3994-4003.
57. Ye, X., Rivera, V. M., Zoltick, P., Cerasoli, Jr. F., Schnell, M. A. (1999). "Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer." Science 283(5398): 88-91.
58. Zabner, J., Seiler, M., Walters, R., Kotin, R. M., Fulgeras, W., Davidson, B. L. and Chiorini, J. A. (2000). "Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer." J. Virol. 74(8): 3852-8.
59. Zhu (2004). Profound Cardiac and Whole-body Functional Recovery in Heart Failure/Muscular Dystrophy Hamsters by Systemic Delivery of AAV8 Vectors via I.V. or I.P. Route. Xth Parvovirus Workshop, St. Petersburg, FL.
60. Zoltick, P. W. and Wilson, J. M. (2000). "A quantitative nonimmunogenic transgene product for evaluating vectors in nonhuman primates." Mol. Ther. 2(6): 657-9.